Vaccines specifically designed to tackle new variants of coronavirus should be ready to be rolled out by October, according to the team behind the Oxford University/AstraZeneca jab.
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.


